Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
S100A8/A9: From basic science to clinical application.
Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Cognitive impairment in MS: rehabilitation approaches.
Task-dependent deterioration of balance underpinning cognitive-postural interference in MS.
Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients.
[Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis].
EVASEP: A Noninterventional Study Describing the Perception of Neurologists, Patients, and Caregivers on Caregivers' Role in the Support of Patients Suffering from Multiple Sclerosis Treated with Subcutaneous Interferon Beta 1a.
The effects of whole body vibration on muscle strength and functional mobility in persons with multiple sclerosis: A systematic review and meta-analysis.
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.
Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case.
The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients.
Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study.
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis.
Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
Safety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis.
Ischemia/reperfusion injury in vascularized tissue allotransplantation: tissue damage and clinical relevance.
Weighted-SAMGSR: combining significance analysis of microarray-gene set reduction algorithm with pathway topology-based weights to select relevant genes.
Neuron-Microglia Interaction Induced Bi-directional Cytotoxicity Associated with Calpain Activation.
Clinical Profile of Patients Requiring Prolonged Mechanical Ventilation and their Outcome in a Tertiary Care Medical ICU.